This topic contains a solution. Click here to go to the answer

Author Question: Ryan Sutherland is the CEO of Nuvage Mechanisms Inc He feels that the new safety standard ... (Read 46 times)

haleyc112

  • Hero Member
  • *****
  • Posts: 600
Ryan Sutherland is the CEO of Nuvage Mechanisms Inc He feels that the new safety standard promulgated by the Secretary of Labor would adversely affect operational efficiency and financial outlay at his firm. In order to file a challenge against the validity of the new standard, he has to file them before the sixtieth day after the issuance of the standard with the appropriate:
 A) District Court.
 B) Court of General Jurisdiction.
 C) Federal Court of Appeals.
 D) U.S. Supreme Court.

Question 2

Not counting the Federal Circuit, there are_____________geo graphically-based U.S. circuit courts of appeals.
 a. three
  b. ten
  c. twelve d. fifteen e. fifty



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

taylorsonier

  • Sr. Member
  • ****
  • Posts: 377
Answer to Question 1

C

Answer to Question 2

c




taylorsonier

  • Sr. Member
  • ****
  • Posts: 377

 

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

For a complete list of videos, visit our video library